The only treatment for celiac disease is strict adherence to a gluten-free diet and, in an ideal world, compliance with this treatment would reverse all symptoms and physical attributes of the disease (i.e. damage to the small intestine). Unfortunately, that is not always the case; many patients continue to experience a wide range of symptoms and, in some cases, persistent intestinal damage in the form of villous atrophy (flattened villi). Researchers at Columbia University sought to more closely analyze these cases.
5/23/2017
Medication Use Associated with Persistent Villous Atrophy
Recent Posts
- Celiac Disease Foundation and SSCD Submit Comments on FDA Draft Guidance for Developing Drugs for Adjunctive Treatment to a Gluten-Free Diet
- Celiac Disease Foundation Excellence in Celiac Disease Research and Young Investigator Prize Recipients Donate Prize Funds to Benefit the Celiac Community
- CDF Announces Recipients of Inaugural Celiac Disease Research Prizes
- New Tool in Development to Improve Pediatric Celiac Disease Research - Marilyn's Message April 2022
Search the archive
Categories
- Advocacy News
- Celiac Disease in the News
- Clinical Trials
- Eat! Gluten-Free
- Featured
- Foundation Press
- iCureCeliac
- Marilyn’s Message
- Monthly eNewsletter
- Research News
- Trending Topics
Marilyn's Message
5/11/2022
Read moreCDF Announces Recipients of Inaugural Celiac Disease Research Prizes